What does your research need to move forward?
See how ACP can help you get there.
Biosamples
Access deeply characterized samples from the ACP Repository, with extensive linked data.
Explore the ACP RepositoryData
Access longitudinal, clinical, genomic, molecular, and participant-reported datasets.
Explore ACP dataCommunity
Tap into an engaged community of people affected by MS ready to participate in and help guide research.
Explore iConquerMSResearch Partnership
Work with ACP to plan and execute studies, from participant recruitment and data collection to clinical trials.
Explore research partnershipsA research ecosystem 25 years in the making
ACP’s resources work together to move research forward.
Research-ready samples
Access biosamples from 3,200+ people with MS and related demyelinating diseases, deeply characterized and ready for your research.
Cloud-based data access
Analyze longitudinal data from REAL-MS, ACP’s decade-long participant-reported study, alongside rich datasets generated through ACP-supported research—all on a secure, cloud-based platform accessible from anywhere.
Insights research & data collection
Understand the experiences, needs, and priorities of people living with MS through surveys, interviews, focus groups, advisory boards, and custom data and sample collection.
MS community partnership
Engage 11,000+ people affected by MS to inform research, collect new data and biosamples, and support study participation.
Inclusive research expertise
Draw on ACP’s inclusive research expertise, tools, and community partnerships to broaden participation and bring more perspectives into research.
Clinical trials and research partnerships
ACP supports clinical trials and other research studies from planning through execution, with capabilities including multichannel recruitment, IRB submission, data collection, decentralized biosample collection, and funding proposal support.
CAFE-MS: Virtual Therapy for MS Fatigue
A $4.4M DoD-funded hybrid trial combining virtual participation with VA clinical sites, with ACP serving as principal investigator and recruiting through iConquerMS.
Novartis: Measuring the Wearing-Off Effect
ACP engaged 135 iConquerMS members to investigate whether MS symptoms change between doses of Ocrevus or Kesimpta.
STEP for MS: Comparing Exercise Delivery Methods
ACP supported participant recruitment, communication, and data collection for a multi-site trial comparing home- and facility-based exercise programs.
Get ACP news in your inbox
Sign up to receive research updates, funding opportunities, new resources, and ways to work with ACP.
Subscribe